Literature DB >> 23567798

Fibronectin conformation regulates the proangiogenic capability of tumor-associated adipogenic stromal cells.

Alwin M D Wan1, Emily M Chandler, Maya Madhavan, David W Infanger, Christopher K Ober, Delphine Gourdon, George G Malliaras, Claudia Fischbach.   

Abstract

BACKGROUND: Changes in fibronectin (Fn) matrix remodeling contribute to mammary tumor angiogenesis and are related to altered behavior of adipogenic stromal cells; yet, the underlying mechanisms remain unclear due in part to a lack of reductionist model systems that allow the inherent complexity of cell-derived extracellular matrices (ECMs) to be deciphered. In particular, breast cancer-associated adipogenic stromal cells not only enhance the composition, quantity, and rigidity of deposited Fn, but also partially unfold these matrices. However, the specific effect of Fn conformation on tumor angiogenesis is undefined.
METHODS: Decellularized matrices and a conducting polymer device consisting of poly(3,4-ethylenedioxythiophene) doped with poly(styrenesulfonate) (PEDOT:PSS) were used to examine the effect of Fn conformation on the behavior of 3T3-L1 preadipocytes. Changes in cell adhesion and proangiogenic capability were tested via cell counting and by quantification of vascular endothelial growth factor (VEGF) secretion, respectively. Integrin-blocking antibodies were utilized to examine varied integrin specificity as a potential mechanism.
RESULTS: Our findings suggest that tumor-associated partial unfolding of Fn decreases adhesion while enhancing VEGF secretion by breast cancer-associated adipogenic precursor cells, and that altered integrin specificity may underlie these changes. CONCLUSIONS AND GENERAL SIGNIFICANCE: These results not only have important implications for our understanding of tumorigenesis, but also enhance knowledge of cell-ECM interactions that may be harnessed for other applications including advanced tissue engineering approaches. This article is part of a Special Issue entitled Organic Bioelectronics - Novel Applications in Biomedicine.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23567798      PMCID: PMC3688647          DOI: 10.1016/j.bbagen.2013.03.033

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.

Authors:  T Sethi; R C Rintoul; S M Moore; A C MacKinnon; D Salter; C Choo; E R Chilvers; I Dransfield; S C Donnelly; R Strieter; C Haslett
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

Review 2.  Polymers for pro- and anti-angiogenic therapy.

Authors:  Claudia Fischbach; David J Mooney
Journal:  Biomaterials       Date:  2007-01-10       Impact factor: 12.479

3.  Preparation of extracellular matrices produced by cultured and primary fibroblasts.

Authors:  Dorothy A Beacham; Michael D Amatangelo; Edna Cukierman
Journal:  Curr Protoc Cell Biol       Date:  2007-01

4.  Preparation of a flexible, porous polyacrylamide substrate for mechanical studies of cultured cells.

Authors:  Y L Wang; R J Pelham
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

5.  Stroma-derived three-dimensional matrices are necessary and sufficient to promote desmoplastic differentiation of normal fibroblasts.

Authors:  Michael D Amatangelo; Daniel E Bassi; Andrés J P Klein-Szanto; Edna Cukierman
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 6.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

7.  Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.

Authors:  Maria Mitsi; Zhenning Hong; Catherine E Costello; Matthew A Nugent
Journal:  Biochemistry       Date:  2006-08-29       Impact factor: 3.162

8.  VEGF-integrin interplay controls tumor growth and vascularization.

Authors:  Sarmishtha De; Olga Razorenova; Noel Patrick McCabe; Timothy O'Toole; Jun Qin; Tatiana V Byzova
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

9.  Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports.

Authors:  Timothy A Petrie; Jeffrey R Capadona; Catherine D Reyes; Andrés J García
Journal:  Biomaterials       Date:  2006-07-18       Impact factor: 12.479

10.  Mesenchymal stem cells within tumour stroma promote breast cancer metastasis.

Authors:  Antoine E Karnoub; Ajeeta B Dash; Annie P Vo; Andrew Sullivan; Mary W Brooks; George W Bell; Andrea L Richardson; Kornelia Polyak; Ross Tubo; Robert A Weinberg
Journal:  Nature       Date:  2007-10-04       Impact factor: 49.962

View more
  15 in total

1.  Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells.

Authors:  Young Hye Song; Christine Warncke; Sung Jin Choi; Siyoung Choi; Aaron E Chiou; Lu Ling; Han-Yuan Liu; Susan Daniel; Marc A Antonyak; Richard A Cerione; Claudia Fischbach
Journal:  Matrix Biol       Date:  2016-11-29       Impact factor: 11.583

Review 2.  Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity.

Authors:  Huan Cao; Lixia Duan; Yan Zhang; Jun Cao; Kun Zhang
Journal:  Signal Transduct Target Ther       Date:  2021-12-16

3.  Protein-crystal interface mediates cell adhesion and proangiogenic secretion.

Authors:  Fei Wu; Weisi Chen; Brian Gillis; Claudia Fischbach; Lara A Estroff; Delphine Gourdon
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

4.  3D Conducting Polymer Platforms for Electrical Control of Protein Conformation and Cellular Functions.

Authors:  Alwin Ming-Doug Wan; Sahika Inal; Tiffany Williams; Karin Wang; Pierre Leleux; Luis Estevez; Emmanuel P Giannelis; Claudia Fischbach; George G Malliaras; Delphine Gourdon
Journal:  J Mater Chem B       Date:  2015-07-07       Impact factor: 6.331

Review 5.  Utilizing Fibronectin Integrin-Binding Specificity to Control Cellular Responses.

Authors:  Haylee Bachman; John Nicosia; Marilyn Dysart; Thomas H Barker
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730

6.  Heparin-dependent regulation of fibronectin matrix conformation.

Authors:  Brant Hubbard; Jo Ann Buczek-Thomas; Matthew A Nugent; Michael L Smith
Journal:  Matrix Biol       Date:  2013-10-19       Impact factor: 11.583

Review 7.  In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer.

Authors:  Bo Ri Seo; Peter DelNero; Claudia Fischbach
Journal:  Adv Drug Deliv Rev       Date:  2013-12-02       Impact factor: 15.470

8.  Cooperative effects of fibronectin matrix assembly and initial cell-substrate adhesion strength in cellular self-assembly.

Authors:  James R Brennan; Denise C Hocking
Journal:  Acta Biomater       Date:  2015-12-19       Impact factor: 8.947

9.  The fibronectin ED-A domain enhances recruitment of latent TGF-β-binding protein-1 to the fibroblast matrix.

Authors:  Franco Klingberg; Grace Chau; Marielle Walraven; Stellar Boo; Anne Koehler; Melissa L Chow; Abby L Olsen; Michelle Im; Monika Lodyga; Rebecca G Wells; Eric S White; Boris Hinz
Journal:  J Cell Sci       Date:  2018-03-01       Impact factor: 5.235

10.  Effect of the Materials Properties of Hydroxyapatite Nanoparticles on Fibronectin Deposition and Conformation.

Authors:  Fei Wu; Debra D W Lin; Jin Ho Chang; Claudia Fischbach; Lara A Estroff; Delphine Gourdon
Journal:  Cryst Growth Des       Date:  2015-04-14       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.